- Home
- SNY vs FINW Comparison
SNY vs FINW Comparison
Compare SNY & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- FINW
- Stock Information
- Founded
- SNY 1994
- FINW 1999
- Country
- SNY France
- FINW United States
- Employees
- SNY N/A
- FINW N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- FINW Commercial Banks
- Sector
- SNY Health Care
- FINW Finance
- Exchange
- SNY Nasdaq
- FINW Nasdaq
- Market Cap
- SNY 123.6B
- FINW 192.3M
- IPO Year
- SNY N/A
- FINW 2021
- Fundamental
- Price
- SNY $49.90
- FINW $14.58
- Analyst Decision
- SNY Buy
- FINW Buy
- Analyst Count
- SNY 2
- FINW 4
- Target Price
- SNY $62.50
- FINW $20.75
- AVG Volume (30 Days)
- SNY 3.1M
- FINW 24.7K
- Earning Date
- SNY 04-24-2025
- FINW 04-30-2025
- Dividend Yield
- SNY 3.21%
- FINW N/A
- EPS Growth
- SNY 39.56
- FINW N/A
- EPS
- SNY 5.45
- FINW 0.91
- Revenue
- SNY $48,817,552,946.00
- FINW $72,056,000.00
- Revenue This Year
- SNY $5.35
- FINW $43.72
- Revenue Next Year
- SNY $6.69
- FINW $21.32
- P/E Ratio
- SNY $18.73
- FINW $16.22
- Revenue Growth
- SNY N/A
- FINW 8.59
- 52 Week Low
- SNY $45.80
- FINW $10.02
- 52 Week High
- SNY $60.12
- FINW $20.94
- Technical
- Relative Strength Index (RSI)
- SNY 37.47
- FINW 43.61
- Support Level
- SNY $51.67
- FINW $13.49
- Resistance Level
- SNY $55.73
- FINW $14.66
- Average True Range (ATR)
- SNY 0.89
- FINW 0.69
- MACD
- SNY -0.12
- FINW 0.03
- Stochastic Oscillator
- SNY 0.34
- FINW 36.56
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.